Meta-analysis of the risk of cataract in type 2 diabetes

BMC Ophthalmology

Volumn 14, Issue 1, 2014, Pages

  Li, Li ^a   Wan, Xiu Hua ^b   Zhao, Guo Hong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Non diabetic; Nuclear sclerosis; Ophthalmology

Indexed keywords

AGING; CATARACT; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEALTH; HUMAN; INCIDENCE; META ANALYSIS; PREVALENCE; RISK; RISK ASSESSMENT; RISK FACTOR;

AGING; CATARACT; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HUMANS; INCIDENCE; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84904528933     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-14-94     Document Type: Article

References (28)

1. Global data on blindness. Thylefors B, Negrel A, Pararajasegaram R, Dadzie K, Bull World Health Organ 1995 73 1 115 7704921
2. Leading causes of blindness worldwide. JMJ R, Bull Soc Belge Ophtalmol 2002 283 19 25 12058483
3. Diabetic cataract-pathogenesis, epidemiology and treatment. Pollreisz A, Schmidt-Erfurth U, J Ophthalmol 2010 2010 1 8
4. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Janghorbani M, Amini M, Ophthalmic Epidemiol 2004 11 5 347 358 10.1080/09286580490888753 15590582 (Pubitemid 40095929)
5. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Jacques PF, Moeller SM, Hankinson SE, Chylack LT Jr, Rogers G, Tung W, Wolfe JK, Willett WC, Taylor A, Am J Clin Nutr 2003 78 3 400 405 12936921 (Pubitemid 39663505)
6. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Klein BE, Klein R, Wang Q, Moss SE, Ophthalmic Epidemiol 1995 2 1 49 55 10.3109/09286589509071451 7585233
7. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Olafsdottir E, Andersson DK, Stefansson E, Acta Ophthalmol 2012 90 4 334 340 10.1111/j.1755-3768.2011.02326.x 22176834
8. Machan CM, Type 2 diabetes mellitus and the prevalence of age-related cataract in a clinic population Waterloo, Ontario, Canada: University of Waterloo 2012
9. The lens opacities classification system III. Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu S-Y, Arch Ophthalmol 1993 111 1506
10. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Prev Med 2007 45 4 247 251 10.1016/j.ypmed.2007.08.012 17950122 (Pubitemid 47562537)
11. Quantitative synthesis in systematic reviews. Lau J, Ioannidis JP, Schmid CH, Ann Intern Med 1997 127 9 820 826 10.7326/0003-4819-127-9-199711010-00008 9382404 (Pubitemid 27465551)
12. Measuring inconsistency in meta-analyses. Higgins JP, Thompson SG, Deeks JJ, Altman DG, BMJ 2003 327 7414 557 10.1136/bmj.327.7414.557 12958120
13. Operating characteristics of a rank correlation test for publication bias. Begg CB, Mazumdar M, Biometrics 1994 50 4 1088 1101 10.2307/2533446 7786990
14. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey Smith G, Schneider M, Minder C, BMJ (Clin Res Ed) 1997 315 7109 629 634 10.1136/bmj.315.7109.629 (Pubitemid 27387172)
15. Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Foster PJ, Wong TY, Machin D, Johnson GJ, Seah SK, Br J Ophthalmol 2003 87 9 1112 1120 10.1136/bjo.87.9.1112 12928278 (Pubitemid 37064887)
16. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Leske MC, Wu SY, Hennis A, Connell AM, Hyman L, Schachat A, Ophthalmology 1999 106 1 35 41 10.1016/S0161-6420(99) 90003-9 9917778
17. Age-related cataract is associated with type 2 diabetes and statin use. Machan CM, Hrynchak PK, Irving EL, Optom Vis Sci 2012 89 8 1165 1171 10.1097/OPX.0b013e3182644cd1 22797512
18. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y, Amoah A, Opoku V, Acheampong J, Agyenim-Boateng K, Ethn Dis 2003 13 2 Suppl 2 110 S117 13677425
19. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study. Tan JS, Wang JJ, Mitchell P, Ophthalmic Epidemiol 2008 15 5 317 327 10.1080/09286580802105806 18850468
20. Cataract surgery and postoperative complications in diabetic patients. Ivancic D, Mandic Z, Barac J, Kopic M, Coll Antropol 2005 29 Suppl 1 55 58 16193678 (Pubitemid 41265100)
21. Cataract: A major secondary diabetic complication. Patel PM, Jivani N, Malaviya S, Gohil T, Bhalodia Y, Int Curr Pharm 2012 1 7 180 185
22. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Squirrell D, Bhola R, Bush J, Winder S, Talbot J, Br J Ophthalmol 2002 86 5 565 571 10.1136/bjo.86.5.565 11973256 (Pubitemid 34454505)
23. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Klein BE, Klein R, Moss SE, Am J Ophthalmol 1995 119 3 295 300 7872389
24. Diabetic cataracts: mechanisms and management. Obrosova IG, Chung SSM, Kador PF, Diabetes Metab Res Rev 2010 26 3 172 180 10.1002/dmrr.1075 20474067
25. Cataract surgical outcomes in diabetic patients: case control study. Onakpoya OH, Bekibele CO, Adegbehingbe SA, Middle East Afr J Ophthalmol 2009 16 2 88 10.4103/0974-9233.53868 20142968
26. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Klein BE, Klein R, Lee KE, Am J Ophthalmol 1998 126 6 782 790 10.1016/S0002-9394(98)00280-3 9860001 (Pubitemid 29001627)
27. Pharmacological prevention of diabetic cataract. Kyselova Z, Stefek M, Bauer V, J Diabetes Complicat 2004 18 2 129 140 10.1016/S1056-8727(03)00009-6 15120709 (Pubitemid 38559078)
28. Single-nucleotide polymorphisms in chromosome 3p14. 1-3p14. 2 are associated with susceptibility of Type 2 diabetes with cataract. Lin H-J, Huang Y-C, Lin J-M, Wu J-Y, Chen L-A, Lin C-J, Tsui Y-P, Chen C-P, Tsai F-J, Mol Vis 2010 16 1206 20664687